A liquid veterinary formulation comprising a stable solution of 6% cyromazine w/v in a solvent system containing water and from 30% to 99% of one or more of the polyethylene glycols. A liquid concentrate is also described in which the cyromazine is dissolved in a liquid PEG and is capable of being diluted with water from 1% v/v to 70% v/v before use.